An investigator-initiated trial to evaluate safety and tolerability of YSCH-01 in patients with recurrent glioblastoma.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Fujian Medical University, Huashan Hospital
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4401514673
